User profiles for "author:L Maloney"
Laurence T MaloneyNew York University Verified email at nyu.edu Cited by 14072 |
Measurement and modeling of depth cue combination: in defense of weak fusion
Various visual cues provide information about depth and shape in a scene. When several of
these cues are simultaneously available in a single location in the scene, the visual system …
these cues are simultaneously available in a single location in the scene, the visual system …
Decision making, movement planning and statistical decision theory
We discuss behavioral studies directed at understanding how probability information is
represented in motor and economic tasks. By formulating the behavioral tasks in the …
represented in motor and economic tasks. By formulating the behavioral tasks in the …
[HTML][HTML] Decision-theoretic models of visual perception and action
LT Maloney, H Zhang - Vision research, 2010 - Elsevier
Statistical decision theory (SDT) and Bayesian decision theory (BDT) are closely related
mathematical frameworks used to model ideal performance in a wide range of visual and …
mathematical frameworks used to model ideal performance in a wide range of visual and …
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled …
…, IA McNeish, CL Scott, T Cameron, L Maloney… - The Lancet, 2017 - thelancet.com
Background Rucaparib, a poly (ADP-ribose) polymerase inhibitor, has anticancer activity in
recurrent ovarian carcinoma harbouring a BRCA mutation or high percentage of genome …
recurrent ovarian carcinoma harbouring a BRCA mutation or high percentage of genome …
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
…, A Leary, TC Harding, S Goble, L Maloney… - The lancet …, 2017 - thelancet.com
Background Poly (ADP-ribose) polymerase (PARP) inhibitors have activity in ovarian
carcinomas with homologous recombination deficiency. Along with BRCA1 and BRCA2 …
carcinomas with homologous recombination deficiency. Along with BRCA1 and BRCA2 …
Color constancy: a method for recovering surface spectral reflectance
LT Maloney, BA Wandell - Readings in Computer Vision, 1987 - Elsevier
Human and machine visual sensing is enhanced when surface properties of objects in
scenes, including color, can be reliably estimated despite changes in the ambient lighting …
scenes, including color, can be reliably estimated despite changes in the ambient lighting …
Evaluation of linear models of surface spectral reflectance with small numbers of parameters
LT Maloney - JOSA A, 1986 - opg.optica.org
Recent computational models of color vision demonstrate that it is possible to achieve exact
color constancy over a limited range of lights and surfaces described by linear models. The …
color constancy over a limited range of lights and surfaces described by linear models. The …
[HTML][HTML] Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY …
…, L Gore, L Chow, S Leong, L Maloney… - Journal of clinical …, 2008 - ncbi.nlm.nih.gov
Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated
Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced …
Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced …
Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian …
High-grade epithelial ovarian carcinomas containing mutated BRCA1 or BRCA2 (BRCA1/2)
homologous recombination (HR) genes are sensitive to platinum-based chemotherapy and …
homologous recombination (HR) genes are sensitive to platinum-based chemotherapy and …
[HTML][HTML] Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)
…, E Dominy, LT Vo, S Goble, L Maloney… - Nature …, 2021 - nature.com
Abstract ARIEL2 (NCT01891344) is a single-arm, open-label phase 2 study of the PARP
inhibitor (PARPi) rucaparib in relapsed high-grade ovarian carcinoma. In this post hoc …
inhibitor (PARPi) rucaparib in relapsed high-grade ovarian carcinoma. In this post hoc …